Company: STAA
Filing Date: 2025-12-19
Form Type: DFAN14A
Source: 0001213900-25-123935
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-12-19
Form: DFAN14A
Chunk 3
---
“STAAR has had more than four
months to justify its ill-advised sale to Alcon. The Company and its would-be acquirer have sought to apply lipstick to this pig of a
deal by conducting a performative go-shop process, issuing more than a dozen press releases, releasing multiple investor presentations
pouring cold water on STAAR’s own prospects – which remain bright – and making hundreds or thousands of phone calls
to shareholders.

There has been ample time and opportunity
for STAAR to tell its story and attempt to cajole shareholders into supporting this misbegotten transaction. Yet, several large shareholders,
all three proxy advisory firms, and at least one of the Company’s own directors have continued to express skepticism about the process,
timing, and price of the proposed transaction. Nevertheless, the Special Meeting has been delayed for a fourth time.
Another few weeks of advocacy and solicitation will not cure the defects of the deal.

Ultimately, the Board cannot avoid shareholder
input forever. For our part, we stand ready to work with the Board and our fellow shareholders to ensure STAAR’s bright future.
In all events, shareholders should be permitted to have their final say on January 6. We urge shareholders to stand firm and vote ‘AGAINST’
the proposed transaction, and we encourage the Board and Alcon to accept the outcome with humility.”

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood
Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”)
are participants in the solicitation of proxies from the shareholders of the Company in connection with the special meeting of shareholders
originally scheduled for October 23, 2025 and most recently postponed to be held on January 6, 2026 (including any further adjournments,
postponements, reschedulings or continuations thereof, the “Proposed Merger Special Meeting”). The Participants have filed
a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GREEN Proxy
Card to be used in connection with any such solicitation of proxies from the Company’s shareholders for the Proposed Merger Special
Meeting. SHARE